P

PULMOCIDE LIMITED

15 employees

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

Basic info

Industry

research

Sectors

Biotechnology
Medical Device
Health Diagnostics
Health Care
Medical

Date founded

2013

Funding rounds raised

Total raised

$92M

from 24 investors over 24 rounds

P

PULMOCIDE LIMITED raised $52M on December 6, 2022

Investors: 旭化成ファーマ（株）, Vivo Capital, JEITO, F-Prime Capital Partners, S.R. One Ltd, Longwood Fund, IP Group plc and SV Life Sciences

P

PULMOCIDE LIMITED raised $92M on May 27, 2021

Investors: 旭化成ファーマ（株）, IP Group plc, Adjuvant Capital, Longwood Fund, S.R. One Ltd, F-Prime Capital Partners, JEITO and SV Life Sciences

P

PULMOCIDE LIMITED raised $30M on March 20, 2017

Investors: F-Prime Capital Partners, Longwood Fund, TOUCHSTONE INNOVATIONS PLC, SV Life Sciences and S.R. One Ltd

P

PULMOCIDE LIMITED raised $27M on November 26, 2013

Investors: F-Prime Capital Partners, SV Life Sciences and Imperial College London

FAQ